Skip to content
Parakho

Sigachi Industries Ltd

NSE SIGACHIBSE 543389sigachi.com

Q1 FY27, unaudited

Revenue
₹121.27 Cr
Profit after tax
₹8.14 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations121.27−5.44%477.83
Other income1.00−74.57%8.25
Total income122.28−7.50%486.08
Employee benefit expense28.45+45.47%110.38
Finance costs3.01−8.87%13.90
Depreciation & amortisation4.41−6.60%17.58
Total expenses112.19+0.01%455.57
Profit before tax10.09+109.99%-87.70
Tax expense1.95+8,900.90%-4.89
Profit after tax8.14+108.07%-82.81
Total comprehensive income10.05+109.95%-79.64
Earnings per share
Earnings per share, basic₹0.18₹-2.14
Earnings per share, diluted₹0.18₹-2.14

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Sigachi Industries reported Q1 FY27 total operating income of INR121.27 crores, EBITDA of INR16.5 crores at a 13.6% margin, and net profit of INR8.14 crores with a 6.76% PAT margin. Management said MCC realizations rose to INR241.36 per kg from INR216 per kg in the prior quarter, while capacity utilization stood at 76.8% across facilities. Management reiterated its FY27 revenue guidance of INR650-675 crores and 18% EBITDA margin target, and discussed the Dahej-2 MCC expansion, CCS facility progress, insurance claim status, and API business ramp-up.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 51 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 07 Oct 2026.